Systemic Sclerosis Clinical Trials

ReadTheTrial indexes 3 studies for Systemic Sclerosis. The most common development stage is Phase 2 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

3 clinical trials found for Systemic Sclerosis.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
67%
Phase 4 1
33%

Trial Status Breakdown

Trials for Systemic Sclerosis

A Phase 1/2 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects With Immune-Mediated Diseases

NCT06733935 · RECRUITING · Phase 2

Upfront Autologous Hematopoietic Stem Cell Transplantation Versus Immunosuppressive Medication in Early Diffuse Cutaneous Systemic Sclerosis: an International Multicentre, Open-label, Randomized Con-trolled Trial

NCT04464434 · COMPLETED · Phase 4

A Randomized, Double-Blind, Placebo-Controlled Study of Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

NCT03844061 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Systemic Sclerosis?

There are 3 clinical trials listed for Systemic Sclerosis. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Systemic Sclerosis trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Systemic Sclerosis trials in?

Current Systemic Sclerosis trials are distributed across: Phase 2 (2), Phase 4 (1).

Find More Trials